Design of trio-colored validated HPLC method for synchronized multianalyte quantitation of four top selling antihyperlipidemic drugs in different fixed-dose combined tablets

Design of trio-colored validated HPLC method for synchronized multianalyte quantitation of four top selling antihyperlipidemic drugs in different fixed-dose combined tablets

The ongoing attempts to attain the sustainable development goals, to save the environment, to embrace the novel paradigm of white analytical chemistry and to focus on the practicality of the technique are non-stoppable. In this consensus, we designed a rapid trio-colored (green, white and blue) anal...

Full description

Bibliographic Details
Main Authors:	Haydi S. Elbordiny, Sohila M. Elonsy, Hoda G Daabees, Tarek S. Belal
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Green Analytical Chemistry
Subjects:	Ezetimibe Atorvastatin Rosuvastatin Simvastatin HPLC whiteness/greenness/blueness evaluation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772577424000090

Similar Items

Development of a sustainable multianalyte MEKC method for quantitation of the antihyperlipidemic drugs ezetimibe together with three statins. Greenness and whiteness appraisal studies
by: Haydi S. Elbordiny, et al.
Published: (2023-09-01)

Impact of lipid-lowering drugs on lipid profile in hyperlipidemia patients
by: Khawla A Shemran, et al.
Published: (2023-01-01)

Chemometric technique for the optimization of chromatographic system: Simultaneous HPLC determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin used in combined cardiovascular therapy
by: V. Sree Janardhanan, et al.
Published: (2016-11-01)

Pharmacokinetic and Bioequivalence Study of the Two-component Drug Product "Ezetimibe + rosuvastatin" (JSC "Sanofi-aventis group", Russia): Resuts and Experience with the Use of Enzymatic Hydrolysis in the Analysis of Samples
by: A. L. Khokhlov, et al.
Published: (2023-02-01)

A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations
by: Hassan A. Alhazmi, et al.
Published: (2017-12-01)

Combination versus monotherapy with statins in patients with type 2 diabetes mellitus of high and very high cardiovascular risk
by: Y. A. Sorokina, et al.
Published: (2019-08-01)

NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE
by: S. Yu. Martsevich
Published: (2015-09-01)

Lower is better: ENHANCE affair
by: Sabino Scardi, et al.
Published: (2016-01-01)

Effect of statins on blood pressure: Analysis on adverse events released by FDA
by: Tao You, et al.
Published: (2017-05-01)

A One-Step Sample Processing Method in Combination with HPLC-MS/MS for the Simultaneous Quantification of Atorvastatin, Ezetimibe and Three Metabolites including <i>o</i>-Hydroxyl Atorvastatin, <i>p</i>-Hydroxyl Atorvastatin, and Ezetimibe-Glucuronide in Human Plasma
by: T. Nguyen Nguyen Le, et al.
Published: (2023-07-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
by: Kim H, et al.
Published: (2018-04-01)

Adverse neurobehavioral changes with reduced blood and brain cholinesterase activities in mice treated with statins
by: Rawnaq Faris Al-Shalchi, et al.
Published: (2024-01-01)

Method development and validation of Atorvastatin, Ezetimibe and Fenofibrate using RP-HPLC along with their forced degradation studies and greenness profiling
by: Viswanathan Sukumar, et al.
Published: (2023-01-01)

THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015
by: S. A. Smetnev, et al.
Published: (2017-01-01)

New Validated Stability-Indicating Rp-HPLC Method for Simultaneous Estimation of Atorvastatin and Ezetimibe in Human Plasma by Using PDA Detector
by: S. Ashutosh Kumar, et al.
Published: (2015-09-01)

An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets
by: Eman A. Mostafa, et al.
Published: (2023-11-01)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
by: Hae Won Jung, et al.
Published: (2023-09-01)

Peripheral polyneuropathy in patients receiving long-term statin therapy
by: Ibrahim Halil Özdemir, et al.
Published: (2019-10-01)

Comparative effect of 1.2% atorvastatin gel and 1.2% rosuvastatin as a local drug delivery in treatment of intra-bony defects in chronic periodontitis
by: Ashish Soni, et al.
Published: (2022-01-01)

Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics
by: Eva González-Iglesias, et al.
Published: (2024-10-01)

Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial
by: Chan Joo Lee, et al.
Published: (2024-03-01)

Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial
by: Keun-Sik Hong, et al.
Published: (2023-05-01)

In vitro and in situ effects of atorvastatin and ezetimibe on P-glycoprotein expression and function
by: Mehran Mesgari Abbasi, et al.
Published: (2016-11-01)

THE ROLE OF STATINS IN PERIODONTAL THERAPY – A REVIEW
by: Anjale Rajagopal, et al.
Published: (2022-06-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment
by: Joon‐Tae Kim, et al.
Published: (2025-02-01)

Study on the Efficacy Differences of Moderate-dose Statin Therapy in Patients with Atherosclerotic Cardiovascular Disease among Different Ethnic Groups
by: LUO Sifu, JIN Menglong, SUBINUER· Jureti, LIU Ziyang, FU Zhenyan
Published: (2024-12-01)

Green chemistry approaches in the analytical validation of fosravuconazole using UV spectrophotometry and HPLC
by: Jeswin Maliyakal, et al.
Published: (2025-03-01)

Comparative analysis of various forms of local drug delivery systems on a class 2 furcation – A systematic review
by: Rishabh Kumar Das, et al.
Published: (2023-01-01)

Quantification of Statins in Pharmaceutical Products Using Screen-Printed Sensors Based of Multi-Walled Carbon Nanotubes and Gold Nanoparticles
by: Ramona Oana Roșca, et al.
Published: (2023-08-01)

Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice
by: Shamuha Bahetibieke, et al.
Published: (2022-06-01)

Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial
by: Sungjoon Park, MD, et al.
Published: (2024-01-01)

Triple-combined hypolipidaemic therapy in familial hypercholesterolaemia: clinical cases
by: Svetlana A. Chepurnenko, et al.
Published: (2021-10-01)

Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
by: R Ara, et al.
Published: (2009-07-01)

Spectrophotometric and TLC-densitometric methods for the simultaneous determination of Ezetimibe and Atorvastatin calcium
by: Yehia Z. Baghdady, et al.
Published: (2013-01-01)

Comprehensive review of greenness, whiteness, and blueness assessments of analytical methods
by: Sherin F. Hammad, et al.
Published: (2025-03-01)

Subgingival Delivery of Statins as an Adjunct in the Non-Surgical Treatment of Periodontitis: A Systematic Review
by: Magdalena Maria Pietrzko, et al.
Published: (2025-01-01)

Preformulation Studies of Ezetimibe-Simvastatin Solid Dispersions in the Development of Fixed-Dose Combinations
by: Agata Górniak, et al.
Published: (2022-04-01)